Vaccination protects against invasive HPV‐associated cancers-Reference-Cited by-同舟云学术

Vaccination protects against invasive HPV‐associated cancers

Published:2018-01-04 Issue:10 Volume:142 Page:2186-2187
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Luostarinen Tapio¹²^ORCID,Apter Dan³,Dillner Joakim²,Eriksson Tiina⁴,Harjula Katja⁴,Natunen Kari⁴,Paavonen Jorma⁵,Pukkala Eero¹⁴,Lehtinen Matti²⁴

Affiliation:

1. Finnish Cancer RegistryHelsinki Finland

2. Department of Laboratory MedicineKarolinska InstituteStockholm Sweden

3. VL‐MediHelsinki Finland

4. School of Health SciencesUniversity of TampereTampere Finland

5. Department of Obstetrics and GynecologyUniversity of HelsinkiHelsinki Finland

Funder

Academy of Finland

Cancer Society of Finland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31231

Reference8 articles.

1. Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

2. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

3. Clinical trials of human papillomavirus vaccines and beyond

4. Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up

5. Ten‐year follow‐up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end‐point—registry‐based follow‐up of three cohorts from randomized trials;Lehtinen M;BMJ Open,2013

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives;Vaccine;2024-09

2. Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control;Viruses;2024-08-25

3. Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study;npj Vaccines;2024-08-13

4. Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study;BMJ;2024-05-15

5. Advances and challenges in cancer immunoprevention and immune interception;Journal for ImmunoTherapy of Cancer;2024-03